Lung function in adult patients with cystic fibrosis after using the eFlow(® )rapid for one year

BACKGROUND: The new generation nebuliser PARI eFlow(® )rapid allows a highly efficient aerosol delivery at reduced inhalation time. However, lung function data during long-term use of this device are not available until now. METHODS: 70 clinically stable adult cystic fibrosis patients participated i...

Descripción completa

Detalles Bibliográficos
Autores principales: Naehrig, S, Lang, S, Schiffl, H, Huber, RM, Fischer, R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3353423/
https://www.ncbi.nlm.nih.gov/pubmed/21463983
http://dx.doi.org/10.1186/2047-783X-16-2-63

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3353423/
https://www.ncbi.nlm.nih.gov/pubmed/21463983
http://dx.doi.org/10.1186/2047-783X-16-2-63

Ejemplares similares